Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
PUT
Strategy Inc
MSTR
$38.4B
| $19.8M | 0.01% |
+298,000
| New | +$17.6M |
|
902
Steel Dynamics
STLD
$37.6B
| $19.8M | 0.01% |
331,879
+106,834
| +47% | +$6.27M |
|
903
Neurocrine Biosciences
NBIX
$16.6B
| $19.8M | 0.01% |
203,004
+127,576
| +169% | +$12.2M |
|
904
Plains All American Pipeline
PAA
$16.1B
| $19.7M | 0.01% |
1,734,700
+173,266
| +11% | +$1.78M |
|
|
HZNP
905
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $19.6M | 0.01% |
209,122
+41,309
| +25% | +$3.8M |
|
906
PUT
State Street SPDR S&P Retail ETF
XRT
$654M
| $19.4M | 0.01% |
+200,000
| New | +$18.7M |
|
907
Enterprise Products Partners
EPD
$81.7B
| $19.4M | 0.01% |
804,089
-13,275
| -2% | -$314K |
|
|
ABMD
908
DELISTED
Abiomed Inc
ABMD
| $19.4M | 0.01% |
62,164
+9,524
| +18% | +$2.92M |
|
909
Invesco S&P 500 Low Volatility ETF
SPLV
$7.22B
| $19.3M | 0.01% |
316,540
+65,415
| +26% | +$3.97M |
|
|
CIT
910
DELISTED
CIT Group Inc.
CIT
| $19.2M | 0.01% |
372,869
+55,307
| +17% | +$2.91M |
|
|
SGG
911
DELISTED
iPath Series B Bloomberg Sugar Subindex Total ReturnSM ETN
SGG
| $19.2M | 0.01% |
344,500
| – | – |
|
912
Canadian National Railway
CNI
$76.6B
| $19.1M | 0.01% |
181,044
+51,158
| +39% | +$5.65M |
|
913
Encompass Health
EHC
$12.4B
| $19M | 0.01% |
306,661
+273,225
| +817% | +$18.2M |
|
|
BAND
914
Bandwidth Inc
BAND
$1.61B
| $19M | 0.01% |
137,678
+16,900
| +14% | +$2.12M |
|
|
STOR
915
DELISTED
STORE Capital Corporation
STOR
| $19M | 0.01% |
549,635
+56,080
| +11% | +$1.95M |
|
916
Arch Capital
ACGL
$33.6B
| $18.9M | 0.01% |
486,186
-86,793
| -15% | -$3.44M |
|
917
CALL
Delta Air Lines
DAL
$60.1B
| $18.9M | 0.01% |
436,600
| – | – |
|
918
Norwegian Cruise Line
NCLH
$8.84B
| $18.9M | 0.01% |
641,307
+186,375
| +41% | +$5.62M |
|
919
iShares 7-10 Year Treasury Bond ETF
IEF
$47.3B
| $18.8M | 0.01% |
163,151
+17,814
| +12% | +$2.04M |
|
920
Reliance Steel & Aluminium
RS
$21.6B
| $18.8M | 0.01% |
124,468
+81,333
| +189% | +$13.2M |
|
921
Arvinas
ARVN
$572M
| $18.7M | 0.01% |
243,478
-29,154
| -11% | -$2.02M |
|
922
Coherent
COHR
$74.2B
| $18.7M | 0.01% |
257,575
+164,480
| +177% | +$11.6M |
|
923
Parsons
PSN
$5.08B
| $18.7M | 0.01% |
474,691
+4,073
| +0.9% | +$167K |
|
924
Cognex
CGNX
$11.3B
| $18.6M | 0.01% |
221,653
+109,890
| +98% | +$8.89M |
|
925
Alcoa
AA
$13.2B
| $18.6M | 0.01% |
504,998
-22,608
| -4% | -$822K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.